113 related articles for article (PubMed ID: 9027768)
21. Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 2: Synthesis and inhibitory activity of aryl-3-trifluoromethylpyrazoles.
Yonetoku Y; Kubota H; Okamoto Y; Ishikawa J; Takeuchi M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2006 Aug; 14(15):5370-83. PubMed ID: 16616503
[TBL] [Abstract][Full Text] [Related]
22. [Effects of calcium antagonists on cardiac cells].
Iijima T
Nihon Rinsho; 1989 Aug; 47(8):1753-8. PubMed ID: 2555589
[No Abstract] [Full Text] [Related]
23. Lead discovery and optimization of T-type calcium channel blockers.
Park JH; Choi JK; Lee E; Lee JK; Rhim H; Seo SH; Kim Y; Doddareddy MR; Pae AN; Kang J; Roh EJ
Bioorg Med Chem; 2007 Feb; 15(3):1409-19. PubMed ID: 17150365
[TBL] [Abstract][Full Text] [Related]
24. [Renal protective effects of calcium antagonists].
Musialik D; Raszeja-Wanic B; Tylarski A
Pol Merkur Lekarski; 1996 Oct; 1(4):266-70. PubMed ID: 9156942
[TBL] [Abstract][Full Text] [Related]
25. [Renal protective action of T-, L-, and N-type Ca channel blockers].
Hayashi K
Nihon Rinsho; 2004 Mar; 62 Suppl 3():654-61. PubMed ID: 15171451
[No Abstract] [Full Text] [Related]
26. [Calcium channel as molecular target of drug action].
Taglialatela M; Annunziato L; Marino A
Clin Ter; 1989 Dec; 131(5):299-305. PubMed ID: 2558001
[TBL] [Abstract][Full Text] [Related]
27. Learning experiences from UNC. Renal autoregulation, drugs, and acute renal failure.
Blythe WB
N C Med J; 1985 Jul; 46(7):413-4. PubMed ID: 2993929
[No Abstract] [Full Text] [Related]
28. Calcium antagonists and the kidney.
Chellingsworth M; Kendall MJ
J Hum Hypertens; 1987 Jun; 1(1):3-8. PubMed ID: 3334055
[TBL] [Abstract][Full Text] [Related]
29. Calcium antagonists and the kidney: implications for renal protection.
Epstein M
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S64-70. PubMed ID: 1725007
[TBL] [Abstract][Full Text] [Related]
30. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers].
Kitamura K; Ogata R
Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831
[No Abstract] [Full Text] [Related]
31. Calcium antagonists and renal failure progression.
Robles NR
Ren Fail; 2008; 30(3):247-55. PubMed ID: 18350443
[TBL] [Abstract][Full Text] [Related]
32. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
[TBL] [Abstract][Full Text] [Related]
33. Renal effects of calcium antagonists in diabetes mellitus. An overview of studies in animal models and in humans.
Bakris GL
Am J Hypertens; 1991 Jul; 4(7 Pt 2):487S-493S. PubMed ID: 1910642
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers.
Renneberg D; Hubler F; Rey M; Hess P; Delahaye S; Gatfield J; Iglarz M; Hilpert K
Bioorg Med Chem Lett; 2015 Sep; 25(18):3941-6. PubMed ID: 26231163
[TBL] [Abstract][Full Text] [Related]
35. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
Greven J
Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
[TBL] [Abstract][Full Text] [Related]
36. [Voltage-gated calcium channels].
Kamkin AG; Kiseleva IS; Kirishchuk SI; Lozinskiĭ IT
Usp Fiziol Nauk; 2006; 37(4):3-33. PubMed ID: 17139998
[TBL] [Abstract][Full Text] [Related]
37. Effect of the two new calcium channel blockers mebudipine and dibudipine in comparison to amlodipine on vascular flow of isolated kidney of diabetic rat.
Sepehr-Ara L; Sepehr-Ara M; Mahmoudian M
Acta Physiol Hung; 2010 Sep; 97(3):281-9. PubMed ID: 20843766
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic aspects of benzothiazepines: a class of antiarrhythmic drugs.
Yadav A; Awasthi A; Rao NK
Eur J Med Chem; 2009 Jan; 44(1):1-6. PubMed ID: 18407379
[TBL] [Abstract][Full Text] [Related]
39. Calcium channel blockers and renal dysfunction in arterial hypertension.
Díez J
Nephrol Dial Transplant; 1995; 10 Suppl 6():22-6. PubMed ID: 8524489
[TBL] [Abstract][Full Text] [Related]
40. T-type calcium channels: from discovery to channelopathies, 25 years of research.
Shuba YM; Perez-Reyes E; Lory P; Noebels J
Channels (Austin); 2008; 2(4):299-302. PubMed ID: 18769138
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
